2016 San Antonio Breast Cancer Symposium Coverage
By Caroline Durham on December 16th, 2016 Categories: Research NewsEvery December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below. We’ll be adding updates and links to the top of this page.
Research News
Untreated Long-Term Side Effects of Breast Cancer Treatment Can Lead to Anxiety, Depression
Adding Afinitor to Faslodex Helps Treat Metastatic Disease That’s …
What My Patients Are Asking: Can the Type of Anesthesia I Get Affect My Risk of Recurrence?
By Brian Wojciechowski, M.D. on October 18th, 2016 Categories: Research NewsSurgery is almost always part of the treatment plan for early-stage breast cancer. Whether the surgery is mastectomy or lumpectomy depends on a number of factors, including the characteristics of the cancer, a woman’s medical history, and her personal preferences.
Patients have asked me about any links between the type of anesthesia used during breast cancer surgery.
I searched the National Library of Medicine database…
2015 San Antonio Breast Cancer Symposium Coverage
By Claire Nixon on December 14th, 2015 Categories: Research NewsWe’re proud to bring you our coverage of the 2015 San Antonio Breast Cancer Symposium! Below you can find our coverage of breast cancer study results presented December 8-12, 2015 in San Antonio, TX. Keep checking this page for updates in Research News and podcasts with our experts!
[Editor’s Note: Updates will be added to the top of this page.]
Dec 22, …
Our Friends Answer: What Do You Think of the New Breast Cancer Screening Guidelines?
By Caroline Durham on November 12th, 2015 Categories: Research NewsThe American Cancer Society (ACS) made news on October 20 when they released updated breast cancer screening guidelines. The new guidelines recommend that women at average risk start regular annual screening with mammography at age 45 and move to screening every 2 years at age 55. The guidelines also say that women ages 40 to 44 should have the option to begin screening early, …
What My Patients Are Asking: What Do the TAILORx Trial Results Mean For Me?
By Brian Wojciechowski, M.D. on October 30th, 2015 Categories: Research NewsFirst results from the TAILORx trial (Trial Assigning IndividuaLized Options for Treatment) were published on Sept. 28, 2105 by the New England Journal of Medicine.
This powerful study showed that women eligible for the Oncotype DX test and who have an Oncotype DX Recurrence Score between 0 and 10 can safely skip chemotherapy.
The Oncotype DX test is a genomic test that analyzes the …
